HALB (Halberd) Total Operating Expense: $0.45 Mil (TTM As of Jul. 2023)


What is Halberd Total Operating Expense?

Halberd HALB -1.05% Total Operating Expense is $0.45 Mil as of Jul. 2023.

Halberd's Total Operating Expense for the six months ended in Jul. 2023 was $0.45 Mil. Halberd's Total Operating Expense for the trailing twelve months (TTM) ended in Jul. 2023 was $0.45 Mil.

Halberd Total Operating Expense Related Terms

Halberd Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Halberd's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd Total Operating Expense Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Total Operating Expense
0.04 1.63 0.45

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Total Operating Expense 0.04 1.63 0.45

Halberd Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in Jul. 2023 was $0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.45 Mil mean?
Halberd (HALB) has a Total Operating Expense of $0.45 Mil as of Jul. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Halberd and its competitors.
Is Halberd's Total Operating Expense too high?
Halberd's current Total Operating Expense is $0.45 Mil.
How does Halberd's Total Operating Expense compare to GRI and OCEA?
Halberd's Total Operating Expense of $0.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Halberd and its competitors. Halberd's current Total Operating Expense is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Halberd stock overvalued right now?
Halberd (HALB) has a current Total Operating Expense of $0.45 Mil. The current Total Operating Expense is $0.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Halberd (HALB), the current Total Operating Expense is $0.45 Mil as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.